2
|
Popov A, Abdullah Z, Wickenhauser C, Saric T, Driesen J, Hanisch FG, Domann E, Raven EL, Dehus O, Hermann C, Eggle D, Debey S, Chakraborty T, Krönke M, Utermöhlen O, Schultze JL. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest 2006; 116:3160-70. [PMID: 17111046 PMCID: PMC1636691 DOI: 10.1172/jci28996] [Citation(s) in RCA: 113] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2006] [Accepted: 09/19/2006] [Indexed: 12/12/2022] Open
Abstract
Control of pathogens by formation of abscesses and granulomas is a major strategy of the innate immune system, especially when effector mechanisms of adaptive immunity are insufficient. We show in human listeriosis that DCs expressing indoleamine 2,3-dioxygenase (IDO), together with macrophages, are major cellular components of suppurative granulomas in vivo. Induction of IDO by DCs is a cell-autonomous response to Listeria monocytogenes infection and was also observed in other granulomatous infections with intracellular bacteria, such as Bartonella henselae. Reporting on our use of the clinically applied anti-TNF-alpha antibody infliximab, we further demonstrate in vitro that IDO induction is TNF-alpha dependent. Repression of IDO therefore might result in exacerbation of granulomatous diseases observed during anti-TNF-alpha therapy. These findings place IDO(+) DCs not only at the intersection of innate and adaptive immunity but also at the forefront of bacterial containment in granulomatous infections.
Collapse
Affiliation(s)
- Alexey Popov
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Zeinab Abdullah
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Claudia Wickenhauser
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Tomo Saric
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Julia Driesen
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Franz-Georg Hanisch
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Eugen Domann
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Emma Lloyd Raven
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Oliver Dehus
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Corinna Hermann
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Daniela Eggle
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Svenja Debey
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Trinad Chakraborty
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Martin Krönke
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Olaf Utermöhlen
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| | - Joachim L. Schultze
- Molecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine,
Institute for Medical Microbiology, Immunology and Hygiene,
Institute for Pathology,
Institute for Neurophysiology,
Institute for Biochemistry II, and
Center for Molecular Medicine, University of Cologne, Cologne, Germany.
Institute of Medical Microbiology, University of Giessen, Giessen, Germany.
Department of Chemistry, University of Leicester, Leicester, United Kingdom.
Department of Biochemical Pharmacology, University of Konstanz, Konstanz, Germany
| |
Collapse
|